Cargando…
Management of Polydrug-Resistant Tuberculosis
Background and Objectives: There is a lack of information regarding the effective duration of treatment necessary to prevent the development of acquired resistance when fluoroquinolones (FQ), and/or pyrazinamide (Z) resistance has occurred in patients with polydrug-resistant tuberculosis and isoniaz...
Autores principales: | Ortakoylu, Mediha Gonenc, Kibar Akilli, Isil, Kilic, Lutfiye, Akbaba Bagci, Belma, Akalin, Esma Seda, Aksan, Arzu Deniz, Toprak, Sezer, Mirsaeidi, Mehdi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967441/ https://www.ncbi.nlm.nih.gov/pubmed/36837448 http://dx.doi.org/10.3390/medicina59020246 |
Ejemplares similares
-
Evaluation of treatment regimens and long-term clinical outcomes in patients with isoniazid-resistant pulmonary tuberculosis: a 5-year follow-up
por: ASLAN, Ayşe Feyza, et al.
Publicado: (2023) -
Value of neutrophil/lymphocyte ratio in the differential diagnosis of sarcoidosis and tuberculosis
por: Iliaz, Sinem, et al.
Publicado: (2014) -
Co-infection of COVID-19 and Tuberculosis
por: Kılıç, Lütfiye, et al.
Publicado: (2022) -
Benign Solitary Pulmonary Necrotic Nodules: How Effectively Does Pathological Examination Explain the Cause?
por: Urer, Halide Nur, et al.
Publicado: (2020) -
Interferon-Inducible Protein-10 as a Marker to Detect Latent Tuberculosis Infection in Patients with Inflammatory Rheumatic Diseases
por: Ortakoylu, Mediha Gonenc, et al.
Publicado: (2022)